We are live on ! Find out more
4WM

49 Wealth Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.81%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$939M
AUM Growth
+$109M
Cap. Flow
+$97.7M
Cap. Flow %
10.4%
Top 10 Hldgs %
69.92%
Holding
202
New
13
Increased
89
Reduced
73
Closed
24
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
151
Linde
LIN
$234B
$248K 0.03%
529
+27
+5% +$12.3K
UBER icon
152
Uber
UBER
$139B
$244K 0.03%
+2,612
New +$215K
FYC icon
153
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.26B
$242K 0.03%
3,046
-323
-10% -$23.2K
VTI icon
154
Vanguard Total Stock Market ETF
VTI
$655B
$242K 0.03%
797
-71
-8% -$20K
TMDX icon
155
Transmedics
TMDX
$2.57B
$235K 0.03%
+1,757
New +$193K
SPGP icon
156
Invesco S&P 500 GARP ETF
SPGP
$2.22B
$233K 0.02%
2,162
-4,218
-66% -$421K
MS icon
157
Morgan Stanley
MS
$337B
$232K 0.02%
+1,645
New +$202K
VGT icon
158
Vanguard Information Technology ETF
VGT
$138B
$231K 0.02%
2,792
-224
-7% -$16.3K
IVOO icon
159
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.74B
$229K 0.02%
2,183
+8
+0.4% +$795
QCOM icon
160
Qualcomm
QCOM
$179B
$225K 0.02%
1,413
-129
-8% -$19K
NPKI
161
NPK International
NPKI
$1.19B
$220K 0.02%
25,855
MRK icon
162
Merck
MRK
$323B
$219K 0.02%
2,769
-3,660
-57% -$291K
TPIF icon
163
Timothy Plan International ETF
TPIF
$251M
$219K 0.02%
+6,784
New +$206K
EVH icon
164
Evolent Health
EVH
$429M
$217K 0.02%
19,300
-235
-1% -$2.16K
JMBS icon
165
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.75B
$213K 0.02%
4,721
+59
+1% +$2.63K
FNDB icon
166
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.42B
$212K 0.02%
8,824
+38
+0.4% +$863
USAC icon
167
USA Compression Partners
USAC
$3.72B
$210K 0.02%
8,639
+182
+2% +$4.51K
TJX icon
168
TJX Companies
TJX
$173B
$202K 0.02%
+1,639
New +$208K
MESO
169
Mesoblast
MESO
$1.89B
$194K 0.02%
+17,829
New +$200K
AESI icon
170
Atlas Energy Solutions
AESI
$1.43B
$175K 0.02%
13,094
+260
+2% +$3.55K
INZY
171
DELISTED
Inozyme Pharma
INZY
$163K 0.02%
40,675
-1,175
-3% -$2.91K
MASS icon
172
908 Devices
MASS
$293M
$137K 0.01%
19,188
-26,550
-58% -$148K
COGT icon
173
Cogent Biosciences
COGT
$6.91B
$111K 0.01%
15,508
+2,476
+19% +$13.7K
RUN icon
174
Sunrun
RUN
$2.38B
$103K 0.01%
12,570
-2,189
-15% -$17.2K
ANNX icon
175
Annexon
ANNX
$841M
$29K ﹤0.01%
+12,083
New +$24.2K

Similar funds

49 Wealth Management's Q2 2025 Portfolio in Review

As of Q2 2025, 49 Wealth Management held 202 positions worth $939M, up 13% from $830M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

49 Wealth Management deployed $97.7M of net new capital in Q2 2025, opening 13 new positions and adding to 89 existing holdings. Its largest new stake was Polen High Income ETF: 537,493 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $10.5M trimmed.

  • 49 Wealth Management's largest Q2 2025 buy was Polen High Income ETF: 537,493 shares worth $13.8M.
  • 49 Wealth Management added most to Apple in Q2 2025, an estimated $46.6M increase.
  • 49 Wealth Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $10.5M.
  • 49 Wealth Management fully exited TrueShares Quarterly Bear Hedge ETF in Q2 2025, selling an estimated $28.3M.
  • 49 Wealth Management's ten largest holdings make up 70% of its $939M portfolio in Q2 2025.
  • 49 Wealth Management opened 13 new positions and closed 24 in Q2 2025.
  • 49 Wealth Management's portfolio value rose 13% quarter-over-quarter to $939M.

Based on 49 Wealth Management's 13F filing for Q2 2025, filed 7 Aug 2025.